Avrobio, inc. (AVRO)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
Cash flows from operating activities:
Net loss

-25,973

-22,662

-17,145

-16,055

-17,103

-16,021

-11,591

-10,507

-8,242

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense

283

245

215

200

190

184

130

45

21

Stock-based compensation expense

2,822

1,885

1,797

1,663

1,455

1,079

551

457

109

Amortization of deferred offering costs

-

-

-

-

-

4

11

11

11

Impairment loss of property and equipment

-

-

-

-

-

0

0

0

235

Deferred rent expense

-53

-49

-42

-41

-40

-42

-40

-15

-8

Change in fair value of preferred stock warrant liability

-

-

-

-

-

0

0

150

12

Change in fair value of derivative liability

-

-

-

-

-

0

0

-1,042

-587

Changes in operating assets and liabilities:
Prepaid expenses and other current assets

-976

1,272

-505

2,636

1,485

1,899

370

579

189

Other assets

-319

-

-

-

-

-268

83

-6

306

Accounts payable

-1,443

2,155

-1,153

-645

671

1,189

-2,200

1,591

1,438

Accrued expenses and other current liabilities

635

1,343

2,397

-394

-1,426

3,804

1,607

-450

352

Net cash used in operating activities

-22,434

-18,583

-13,382

-17,965

-17,738

-11,434

-11,985

-8,249

-5,980

Cash flows from investing activities:
Purchases of property and equipment

577

766

78

401

340

493

915

161

263

Net cash used in investing activities

-577

-766

-78

-401

-340

-234

-1,198

-137

-263

Cash flows from financing activities:
Proceeds from exercise of stock options

35

3

9

238

252

-

-

-

-

Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs

-

-

-

-

-

-1

0

-5

58,263

Proceeds from issuance of common shares upon completion of public offering, net of offering costs

93,628

-

-

-

-

-

-

-

-

Payments of initial public offering costs

-

-

-

-

-

-

-

-

55

Net cash provided by financing activities

93,663

30

129,474

238

252

-139

-3,255

105,473

58,208

Net increase (decrease) in cash, cash equivalents and restricted cash

70,652

-19,319

116,014

-18,128

-17,826

-11,807

-16,438

97,087

51,965

Supplemental disclosure of non-cash investing and financing activities:
Purchases of property and equipment included in accounts payable and accrued expenses

-

-

-

-

-

20

-520

668

88

Property and equipment held for sale

-

-

-

-

336

0

0

0

19

Offering costs included in accrued expenses and accounts payable

249

-

-

-

-

-

-

-

-

Deferred offering costs included in accrued expenses

-

-

-

-

-

-

-

734

507

Purchase of property and equipment paid for by landlord

-

-

-

-

-

0

0

661

181

Accretion of issuance costs related to redeemable convertible preferred stock

-

-

-

-

-

3

0

0

2,240